Business and News Update - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
Business and News Update Industry news focusing on the people and organizations who work in the clinical trials profession.

Source: Applied Clinical Trials


Acquisitions

Quintiles (Research Triangle Park, NC) has acquired Outcome Sciences, Inc., a privately held outcomes research firm headquartered in Cambridge, MA.

Aptiv Solutions (Reston, VA) has acquired SRA Global Clinical Development, the CRO division of SRA International, Inc. based in Durham, NC, with offices in Paris, France and Milton Park, England.

Alliances

INC Research (Raleigh, NC) and SAS (Cary, NC) are working together to improve clinical development risk management and achieve targeted product profiles through analytics. They will offer biopharmaceutical customers an integrated suite of tools to increase decision-making speed, efficiency, and flexibility.

ICON (Dublin, Ireland) and Empire Genomics (Buffalo, NY) announced the formation of a strategic alliance to develop a service portfolio tailored to the development of personalized medicines.

TAKE Solutions (Princeton, NJ) has partnered with MENE Research (Istanbul, Turkey) and together will cater to the Drug Safety requirements of Middle East, Europe, and West Asian countries.

Alquest (Northwood, OH) has become the first organization to join MedNet Solutions' (Minnetonka, MN) iMedNet CRO Partner Program.

Boehringer Ingelheim (Ingelheim am Rhein, Germany) has awarded Patheon (Toronto, Canada) two projects with combined revenue of more than $18 million over a three-year period. The projects are both fixed-dose combination drugs in development for the treatment of the growing population of type II diabetics.

Awards


Exco InTouch Wins Best eBusiness/IT Strategy Award at European Outsourcing Awards 2011 in Frankfurt, Germany. The company has been awarded the title "Best eBusiness/IT Strategy," which recognizes Exco InTouch’s collaboration with Pfizer.
Exco InTouch (Sawbridgeworth, UK) has received the European Outsourcing Awards held in Frankfurt. Exco InTouch has been honored with the accolade of "Best eBusiness/IT Strategy," which recognizes Exco InTouch's collaboration with Pfizer.

INTERLAB Central Lab Services—Worldwide (Munich, Germany) has been awarded with the Exportpreis Bayern 2011, the Bavarian Prize for Export Achievements in the Services Sector by the Bavarian Minister of Economy and Technology.

Drug Safety Alliance (Research Triangle Park, NC) has been named a winner in the Triangle Business Journal's "Fast 50" awards for the third straight year. Given to the 50 fastest growing privately held companies in North Carolina's Triangle region, the award honors businesses for their contributions to the growth and success of the community.

Copernicus Group IRB (Research Triangle Park, NC) has been named a finalist in Training Magazine's annual Top 125, which ranks companies' excellence in employer-sponsored training and development programs.

New Facilities

Eurofins Global Central Laboratory has opened a new Central Laboratory in Bangalore, India.

Almac has announced the expansion of its Pharmaceutical Development services with the creation of a new facility at its UK headquarters in Craigavon.

ICON's (Dublin, Ireland) resourcing division, DOCS, has expanded in Europe by opening four new offices in Milan, Italy; Budapest, Hungary; Brussels, Belgium; and Berlin, Germany.

Products

Cmed Technology (New Providence, NJ) has launched Timaeus Guided Trial Builder, a new product that introduces a different approach to reduce the time and effort required to start up electronic trials.

Almac (Craigavon, Northern Ireland) has released its new forecasting platform, COMPASS, which has been designed to improve the accuracy and efficiency of the supply inventory process during clinical studies.


ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

UPCOMING CONFERENCES

8th Annual Forum on Transparency and Aggregate Spend 2014
Washington, DC
August 18-20, 2014

eSource Data in Clinical Investigations
Philadelphia, PA
August 20-21, 2014

Pharmacovigilance 2014
Philadelphia, PA
September 10-11, 2014

Collaborative Research Summit
Philadelphia, PA
October 15-16, 2014

See All Conferences >>

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
87%
Borrow lightly from EMA's pathway program?
6%
Create entirely its own pathway program?
8%
View Results
Untitled Document
Source: Applied Clinical Trials,
Click here